In vivo iron mobilisation evaluation of hydroxypyridinones in 59Fe-ferritin-Loaded rat model

Biochemical Pharmacology

Volumn 57, Issue 5, 1999, Pages 559-566

  Liu, Zu Dong ^a   Lu, Shu Li ^a   Hider, Robert C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

59Fe ferritin; Hydroxypyridinone; Iron chelators; Prodrug

Indexed keywords

FERRITIN; IRON 59; IRON CHELATING AGENT; PYRIDINOL;

ANIMAL TISSUE; ARTICLE; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; IRON KINETICS; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; FERRITINS; IRON; IRON CHELATING AGENTS; IRON RADIOISOTOPES; KINETICS; LIVER; MALE; MODELS, BIOLOGICAL; PYRIDONES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

EID: 0033105983     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00319-0     Document Type: Article

References (27)

1. Pippard M.J., Callender S.T., Letsky E.A., Weatherall D.J. Prevention of iron loading in transfusion-dependent thalassaemia. Lancet. i:1978;1178-1180.
2. Summers M.R., Jacobs A., Tudway D., Perera P., Ricketts C. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects. Br J Haematol. 42:1979;547-555.
3. Pippard M.J., Callender S.T., Weatherall D.J. Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias. Clin Sci Mol Med. 54:1978;99-106.
4. White G.P., Jacobs A., Grady R.W., Cerami A. The use of Chang cells cultured in vitro to evaluate potential iron chelating drugs. Br J Haematol. 33:1976;487-494.
5. Porter J.B., Gyparaki M., Burke L.C. Iron mobilisation from hepatocyte monolayer cultures by chelators the importance of membrane permeability and the iron binding constant . Blood. 72:1988;1497-1503.
6. Graziano J.H., Grady R.W., Cerami A. The identification of 2,3-hydroxybenzoic acid as a potentially useful iron-chelating drug. J Pharmacol Exp Ther. 190:1974;570-575.
7. Grady R.W., Graziano J.H., Akers H.A., Cerami A. The development of new iron chelating drugs. J Pharmacol Exp Ther. 196:1976;478-485.
8. Grady R.W., Graziano J.H., White G.P., Jacobs A., Cerami A. The development of new iron chelating drugs. J Pharmacol Exp Ther. 205:1978;757-765.
9. Gralla EJ, Efforts to develop a bioassay system for detecting compounds which actively deplete iron stores. In: Proceedings of the Symposium on the Development of Iron Chelators for Clinical Use (Eds. Anderson WF and Hille M), pp. 229-245. DHEW Publication, Bethesda, MD, 1975.
10. Pitt C.G., Gupta G., Estes N.E., Rosenkrantz H., Metterville J.J., Crumbliss A.L., Palmer A.R., Nordquest K.W., Sprinkle Hardy K.A., Whitcomb D.R., Byers B.R., Arceneaux J.E.L., Gaines C.G., Sciortino C.V. Selection and evaluation of new chelating agents for the treatment of iron overload. J Pharmacol Exp Ther. 208:1979;12-18.
11. Gyparaki M., Hider R.C., Huehns E.R., Porter J.B. Hydroxypyridinone iron chelators; in vitro and in vivo evaluation. Sirshia G., Zanella A. Thalassaemia Today, the Mediterranean Experience. 1987;521-526 Maggiore Policlinico Di Milano, Milan.
12. Gyparaki M., Porter J.B., Burke L.C., Huehns E.R., Hider R.C. In vivo evaluation of hydroxypyridinone iron chelators in a mouse model. Acta Haematol. 78:1987;217-221.
13. Longueville A., Crichton R.R. An animal model of iron overload and its application to study hepatic ferritin iron mobilisation by chelators. Biochem Pharmacol. 35:1986;3669-3678.
14. Ward R.J., Florence A.L., Baldwin D., Abiaka C., Roland F., Ramsey M.H., Dickson D.P.E., Peters T.J., Crichton R.R. Biochemical and biophysical investigations of the ferrocene-loaded rat. An animal model of primary haemochromatosis. Eur J Biochem. 202:1991;405-410.
15. Florence A., Ward R.J., Peters T.J., Crichton R.R. Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat. Biochem Pharmacol. 44:1992;1023-1027.
16. Hershko C., Cook J.D., Finch C.A. Storage iron kinetics III. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cell. J Lab Clin Med. 81:1973;876-886.
17. Hershko C. A study of the chelating agent diethylenetriaminepentacetic acid using selective radioiron probes of reticuloendothelial and parenchymal iron stores. J Lab Clin Med. 85:1975;913-921.
18. Hershko C. Determinants of faecal and urinary iron excretion in rats. Blood. 51:1978;415-423.
19. Huehns E.R., Porter J.B., Hider R.C. Selection of hydroxypyridin-4-ones for the treatment of iron overload using in vitro and in vivo models. Haematology. 12:1988;593-600.
20. Waxman H.S., Brown E.B. Clinical usefulness of iron chelating agents. Prog Hematol. 6:1969;338-373.
21. Pippard M.J., Johnson D.K., Finch C.A. A rapid assay for evaluation of iron chelating agents in rats. Blood. 58:1981;685-692.
22. Tilbrook G.S., Hider R.C. Iron chelators for clinical use. Sigel A., Sigel H. Metal Ions in Biological Systems. Vol. 35. Iron Transport and Storage in Microorganisms, Plants, and Animals. 1998;691-730 Marcel Dekker, New York.
23. Dobbin P.S., Hider R.C., Hall A.D., Taylor P.D., Sarpong P., Porter J.B., Xiao G., van der Helm D. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones Orally active iron chelators with clinical potential . J Med Chem. 36:1993;2448-2458.
24. Rai BL, Liu ZD and Hider RC, Synthesis, physicochemical properties, and biological evaluation of hydrophobic esters of hydroxypyridin-4-ones: Design of orally active chelators with clinical potential. Eur J Med Chem (in press, 1999).
25. Bjorklid E., Helgeland L. Sex difference in the ferritin content of rat liver. Biochim Biophys Acta. 221:1970;583-592.
26. Zhang D., Okada S., Kawabata T., Yasada T. An improved simple colorimetric method for quantitation of non-transferrin-bound iron in serum. Biochem Mol Biol Int. 35:(3):1995;635-641.
27. Choudhury R, Metabolism and Pharmacokinetics of 1-Hydroxyalkyl-3-hydroxypyridin-4-one Chelating Agents. Ph.D. Thesis. King's College, London, 1995.